APO RESEARCH · REPORT
Diagnostic Radiopharmaceuticals
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
Product & engineering
Understand the product.
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
Selected research
Industry Research
Diagnostic Radiopharmaceuticals Industry Research Report 2026
Market perspective
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
North America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
Report Scope
Read the full market overview
This report quantifies the global Diagnostic Radiopharmaceuticals market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diagnostic Radiopharmaceuticals Market by Company
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Diagnostic Radiopharmaceuticals Segment by Type
Technetium 99
Fluorine 18
Other
Diagnostic Radiopharmaceuticals Segment by Application
Oncology
Cardiology
Other
Diagnostic Radiopharmaceuticals Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Radiopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Diagnostic Radiopharmaceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Diagnostic Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Technetium 99
- Fluorine 18
- Other
Applications
- Oncology
- Cardiology
- Other
Companies covered
- Cardinal Health
- GE Healthcare
- Curium Pharma
- Jubilant Pharma
- Bracco Imaging
- Advanced Accelerator Applications
- SIEMENS
- China Isotope & Radiation
- Dongcheng Pharmaceutical Group
- Lantheus
- Eli Lilly
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Diagnostic Radiopharmaceuticals Market Size (2021-2032)
- 2.2.2 Global Diagnostic Radiopharmaceuticals Sales (2021-2032)
- 2.2.3 Global Diagnostic Radiopharmaceuticals Market Average Price (2021-2032)
- 2.3 Diagnostic Radiopharmaceuticals by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Technetium 99
- 2.3.3 Fluorine 18
- 2.3.4 Other
- 2.4 Diagnostic Radiopharmaceuticals by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oncology
- 2.4.3 Cardiology
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Diagnostic Radiopharmaceuticals Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Diagnostic Radiopharmaceuticals Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Diagnostic Radiopharmaceuticals Revenue of Manufacturers (2021-2026)
- 3.4 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2021-2026)
- 3.5 Global Diagnostic Radiopharmaceuticals Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Diagnostic Radiopharmaceuticals, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Diagnostic Radiopharmaceuticals, Product Type & Application
- 3.8 Global Manufacturers of Diagnostic Radiopharmaceuticals, Established Date
- 3.9 Global Diagnostic Radiopharmaceuticals Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cardinal Health
- 4.1.1 Cardinal Health Company Information
- 4.1.2 Cardinal Health Business Overview
- 4.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
- 4.1.5 Cardinal Health Recent Developments
- 4.2 GE Healthcare
- 4.2.1 GE Healthcare Company Information
- 4.2.2 GE Healthcare Business Overview
- 4.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
- 4.2.5 GE Healthcare Recent Developments
- 4.3 Curium Pharma
- 4.3.1 Curium Pharma Company Information
- 4.3.2 Curium Pharma Business Overview
- 4.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
- 4.3.5 Curium Pharma Recent Developments
- 4.4 Jubilant Pharma
- 4.4.1 Jubilant Pharma Company Information
- 4.4.2 Jubilant Pharma Business Overview
- 4.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
- 4.4.5 Jubilant Pharma Recent Developments
- 4.5 Bracco Imaging
- 4.5.1 Bracco Imaging Company Information
- 4.5.2 Bracco Imaging Business Overview
- 4.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
- 4.5.5 Bracco Imaging Recent Developments
- 4.6 Advanced Accelerator Applications
- 4.6.1 Advanced Accelerator Applications Company Information
- 4.6.2 Advanced Accelerator Applications Business Overview
- 4.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
- 4.6.5 Advanced Accelerator Applications Recent Developments
- 4.7 SIEMENS
- 4.7.1 SIEMENS Company Information
- 4.7.2 SIEMENS Business Overview
- 4.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
- 4.7.5 SIEMENS Recent Developments
- 4.8 China Isotope & Radiation
- 4.8.1 China Isotope & Radiation Company Information
- 4.8.2 China Isotope & Radiation Business Overview
- 4.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
- 4.8.5 China Isotope & Radiation Recent Developments
- 4.9 Dongcheng Pharmaceutical Group
- 4.9.1 Dongcheng Pharmaceutical Group Company Information
- 4.9.2 Dongcheng Pharmaceutical Group Business Overview
- 4.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
- 4.9.5 Dongcheng Pharmaceutical Group Recent Developments
- 4.10 Lantheus
- 4.10.1 Lantheus Company Information
- 4.10.2 Lantheus Business Overview
- 4.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
- 4.10.5 Lantheus Recent Developments
- 4.11 Eli Lilly
- 4.11.1 Eli Lilly Company Information
- 4.11.2 Eli Lilly Business Overview
- 4.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
- 4.11.5 Eli Lilly Recent Developments
5 Global Diagnostic Radiopharmaceuticals Market Scenario by Region
- 5.1 Global Diagnostic Radiopharmaceuticals Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Diagnostic Radiopharmaceuticals Sales by Region: 2021-2032
- 5.2.1 Global Diagnostic Radiopharmaceuticals Sales by Region: 2021-2026
- 5.2.2 Global Diagnostic Radiopharmaceuticals Sales by Region: 2027-2032
- 5.3 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2021-2032
- 5.3.1 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2021-2026
- 5.3.2 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2027-2032
- 5.4 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
- 5.4.1 North America Diagnostic Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Diagnostic Radiopharmaceuticals Sales by Country (2021-2032)
- 5.4.3 North America Diagnostic Radiopharmaceuticals Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
- 5.5.1 Europe Diagnostic Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Diagnostic Radiopharmaceuticals Sales by Country (2021-2032)
- 5.5.3 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
- 5.6.1 Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
- 5.7.1 South America Diagnostic Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Diagnostic Radiopharmaceuticals Sales by Country (2021-2032)
- 5.7.3 South America Diagnostic Radiopharmaceuticals Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2021-2032)
- 6.1.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2021-2032)
- 6.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2021-2032)
- 6.2.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
- 6.3 Global Diagnostic Radiopharmaceuticals Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2021-2032)
- 7.1.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2021-2032)
- 7.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2021-2032)
- 7.2.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
- 7.3 Global Diagnostic Radiopharmaceuticals Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Diagnostic Radiopharmaceuticals Value Chain Analysis
- 8.1.1 Diagnostic Radiopharmaceuticals Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Diagnostic Radiopharmaceuticals Production Mode & Process
- 8.2 Diagnostic Radiopharmaceuticals Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Diagnostic Radiopharmaceuticals Distributors
- 8.2.3 Diagnostic Radiopharmaceuticals Customers
9 Global Diagnostic Radiopharmaceuticals Analyzing Market Dynamics
- 9.1 Diagnostic Radiopharmaceuticals Industry Trends
- 9.2 Diagnostic Radiopharmaceuticals Industry Drivers
- 9.3 Diagnostic Radiopharmaceuticals Industry Opportunities and Challenges
- 9.4 Diagnostic Radiopharmaceuticals Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst